GFR PHARMACEUTICALS INC: 10-Q filed 2011-11-08
What GFR PHARMACEUTICALS INC reported in its quarterly report filed 2011-11-08 (fiscal Q3 2011): 32 published measures, 86 facts as tagged in accession 0001437749-11-008215.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-11-08
- Fiscal period
- fiscal Q3 2011
- Accession
- 0001437749-11-008215 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GFR PHARMACEUTICALS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 10,689,674 | USD | |
| At 2010-12-31 | 8,822,320 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,836,268 | USD | |
| At 2010-12-31 | 1,861,052 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 8,177,528 | USD | |
| At 2010-12-31 | 6,358,268 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 448,024 | USD | |
| At 2010-12-31 | 300,716 | USD | |
| At 2010-09-30 | 1,429,840 | USD | |
| At 2009-12-31 | 55,486 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 622,742 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 1,666,404 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 671,692 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,799,644 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 471,496 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 2,292,684 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 302,370 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 719,577 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -33,685 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -223,616 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -302,370 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -719,577 | USD | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 42,079,940 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 42,079,940 | shares | 273 |
| 2010-07-01 to 2010-09-30 | 42,079,940 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 42,079,940 | shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 181,709 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 468,457 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 168,694 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 499,081 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 6,870,325 | USD | |
| At 2010-12-31 | 6,957,273 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 832,976 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 2,206,684 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 858,130 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 2,121,165 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 2,117,547 | USD | |
| At 2010-12-31 | 1,724,119 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 998,091 | USD | |
| At 2010-12-31 | 1,049,497 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 85,228 | USD | |
| At 2010-12-31 | 27,903 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,170,827 | USD | |
| At 2010-12-31 | 1,245,616 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 150,699 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 526,205 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 151,814 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 514,156 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 88,416 | USD | |
| At 2010-12-31 | 35,062 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 983,675 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 2,732,889 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,009,944 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 2,635,321 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 188,448 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 595,089 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 185,074 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 535,962 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 42,079,940 | shares | |
| At 2010-12-31 | 42,079,940 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 466,550 | USD | |
| At 2010-12-31 | 313,694 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 8,853,406 | USD | |
| At 2010-12-31 | 6,961,268 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 402,535 | USD | |
| At 2010-12-31 | 135,226 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 651,604 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 1,739,282 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 699,060 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,877,565 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 134,016 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 521,674 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 112,273 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 378,435 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 618,210 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 574,773 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 337 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 1,055 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 9,624 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 255,481 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -1,382,510 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -240,777 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -44,329 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -5,540 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 55,506 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 203,080 | USD | 273 |
Inspect the source
- Entity
- GFR PHARMACEUTICALS INC / CIK 0001096294
- Captured
- SEC response SHA-256
86308bf73caa2caf65af546f6e008bd3598c2150b1774d4e52782ca5e859abcc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001096294.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))